Unpacking the 'black box' of total pathogen burden: Is number or type of pathogens most predictive of all-cause mortality in the United States?

Epidemiology and Infection

Volumn 143, Issue 12, 2015, Pages 2624-2634

  Simanek, A M ^a   Dowd, J B ^b   Zajacova, A ^c   Aiello, A E ^d  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF WYOMING   (United States)

^d The University of North Carolina at Chapel Hill   (United States)

Author keywords

Cytomegalovirus; Helicobacter pylori; herpes simplex virus; mortality; pathogen burden

Indexed keywords

IMMUNOGLOBULIN G; BACTERIUM ANTIBODY; VIRUS ANTIBODY;

ADULT; AGE; ANTIGEN DETECTION; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; EDUCATION; ETHNICITY; FEMALE; GENDER; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL HEALTH ORGANIZATION; NONHUMAN; PATHOGEN LOAD; PROBABILITY; SEX DIFFERENCE; SMOKING; SURVIVAL RATE; UNITED STATES; VIRUS REPLICATION; BLOOD; CAUSE OF DEATH; CYTOMEGALOVIRUS INFECTIONS; HELICOBACTER INFECTIONS; HERPES SIMPLEX; HETEROZYGOTE; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; MIXED INFECTION; NUTRITION; VIROLOGY;

ADULT; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; CARRIER STATE; CAUSE OF DEATH; COINFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES;

EID: 84938417409     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814003215     Document Type: Article

References (39)

1. O'Connor SM, Taylor CE, Hughes JM. Emerging infectious determinants of chronic diseases. Emerging Infectious Diseases 2006; 12: 1051-1057.
2. Izadi M, et al. Helicobacter species in the atherosclerotic plaques of patients with coronary artery disease. Cardiovascular Pathology 2012; 21: 307-311.
3. Melnick JL, et al. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. Journal of Medical Virology 1994; 42: 170-174.
4. Fraser NW, et al. Herpes simplex type 1 DNA in human brain tissue. Proceedings of the National Academy of Sciences USA 1981; 78: 6461-6465.
5. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315.
6. Epstein SE. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circulation Research 2002; 90: 2-4.
7. Kountouras J, et al. Association between Helicobacter pylori infection and mild cognitive impairment. European Journal of Neurology 2007; 14: 976-982.
8. Tarter KD, et al. Persistent viral pathogens and cognitive impairment across the lifecourse in the Third National Health and Nutrition Examination Survey. Journal of Infectious Diseases 2014; 209: 837-844.
9. Ferreira AC, et al. Helicobacter and gastric malignancies. Helicobacter 2008; 13 (Suppl. 1): 28-34.
10. Soroceanu L, Cobbs CS. Is HCMV a tumor promoter? Virus Research 2011; 157: 193-203.
11. Epstein SE, et al. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arteriosclerosis, Thrombosis, and Vascular Biology 2000; 20: 1417-1420.
12. Nazmi A, et al. The influence of persistent pathogens on circulating levels of inflammatory markers: a crosssectional analysis from the Multi-Ethnic Study of Atherosclerosis. BMC Public Health 2010; 10: 706.
13. Jackson L, et al. A population-based epidemiologic study of Helicobacter pylori infection and its association with systemic inflammation. Helicobacter 2009; 14: 108-113.
14. Emerging Risk Factors Collaboration C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375: 132-140.
15. Simanek AM, Dowd JB, Aiello AE. Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. International Journal of Epidemiology 2009; 38: 775-787.
16. Sealy-Jefferson S, et al. Antibody levels to persistent pathogens and incident stroke in Mexican Americans. PLoS ONE 2013; 8: e65959.
17. Aiello AE, et al. The influence of latent viral infection on rate of cognitive decline over 4 years. Journal of the American Geriatric Society 2006; 54: 1046-1054.
18. Aiello AE, et al. Persistent infection, inflammation, and functional impairment in older latinos. Journals of Gerontology, Series A: Biological Sciences and Medical Sciences 2008; 63: 610-618.
19. Jeon CY, et al. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care 2012; 35: 520-525.
20. Xia HH, et al. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. American Journal of Gastroenterology 2001; 96: 1039-1046.
21. Katan M, et al. Infectious burden and cognitive function: the Northern Manhattan Study. Neurology 2013; 80: 1209-1215.
22. Miller GE, et al. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. American Journal of Cardiology 2005; 95: 317-321.
23. Fernandez-Real J-M, et al. Burden of Infection and insulin resistance in healthy middle-aged men. Diabetes Care 2006; 29: 1058-1064.
24. Zhu J, et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. American Journal of Cardiology 2000; 85: 140-146.
25. Zhu J, et al. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001; 103: 45-51.
26. Elkind MS, et al. Infectious burden and risk of stroke: the northern Manhattan study. Archives of Neurology 2010; 67: 33-38.
27. Staras SA, et al. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clinical Infectious Diseases 2006; 43: 1143-1151.
28. Schillinger JA, et al. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sexually Transmitted Diseases 2004; 31: 753-760.
29. U. S. Department of Health and Human Services (DHHS). National Center for Health Statistics. Third National Health and Nutrition Examination Survey (NHANES III. : 1988-1994. NHANES III Second Laboratory File Documentation Series 11, No. 2A. Hyattsville, Maryland: Centers for Disease Control and Prevention, 1998.
30. Data Linkage Team. Comparative analysis of the NHANES III public-use and restricted-use linked mortality files: 2010 public-use data release. National Center for Health Statistics. March 2010. Hyattsville, Maryland (http://www. cdc. gov/nchs/data/datalinkage/ nhanes3-mort-compare-2010-final. pdf).
31. SUDAAN. Example Manual, Release 10.0.1. Research Triangle Park, NC. : Research Triangle Institute, 2010.
32. Benjamini Y, Hochberg Y. Controlling the false discovery rate-a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B: Methodological 1995; 57: 289-300.
33. Sun Y, et al. Herpes simplex virus type 2 infection is a risk factor for hypertension. Hypertension Research 2004; 27: 541-544.
34. de Luis DA, et al. Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care 1998; 21: 1129-1132.
35. Thomas F, et al. Herpes simplex virus type 2 and cancer: a medical geography approach. Infection, Genetics and Evolution 2011; 11: 1239-1242.
36. Beydoun MA, et al. Helicobacter pylori seropositivity and cognitive performance among US adults: evidence from a large national survey. Psychosomatic Medicine 2013; 75: 486-496.
37. Colberg-Poley AM, Isom HC, Rapp F. Reactivation of herpes simplex virus type 2 from a quiescent state by human cytomegalovirus. Proceedings of the National Academy of Sciences USA 1979; 76: 5948-5951.
38. Colberg-Poley AM, Isom HC, Rapp F. Involvement of an early human cytomegalovirus function in reactivation of quiescent herpes simplex virus type 2. Journal of Virology 1981; 37: 1051-1059.
39. Strachan DP, et al. Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study. British Medical Journal (Clinical Research Edition) 1999; 318: 1035-1039.